All In MedTech

Company

Caredx

Funding, FDA decisions, device trials, adverse event reports and recalls filed under this company's name in public data. Records are matched by name, so a subsidiary or an unusual spelling can be missed.

Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations

This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.

Financing

Public company. Figures from its SEC financial statements, plus private placements it reported on Form D.

Public

Listed

CDNA

Nasdaq · CareDx, Inc.

Public float

$1.00B

Value of shares held by non-insiders on Jun 30, 2025

Revenue

$380M

Fiscal year ending Dec 31, 2025

Net income

-$21.4M

Fiscal year ending Dec 31, 2025

R&D spending

$71.4M

Fiscal year ending Dec 31, 2025

Cash

$250M

As of Sep 30, 2026

Long-term debt

Not reported

Shares outstanding

52.5M

As of Oct 26, 2026

Capital raised as a public company

Cash received from selling stock and borrowing, from each year's cash-flow statement in the annual report. Fiscal years, by the year each one ended.

YearIPOStock soldLong-term debtConvertible debt
2021–$189M––

Private placements (Form D)

One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.

First saleTypeRaisedRound sizeInvestorsExemption and agentFiling
Apr 14, 2016Equity$22.2M$36.8M42Rule 506(b)Agent: M.M. Dillon & Co. Group, CIM Securities, LLCCommissions $1.1MForm D/A ↗Jun 17, 20161 amendment

Company details

From the company's latest Form D.

Legal name
CareDx, Inc.
Headquarters
Brisbane, California
Incorporated
Delaware over five years before filing
Entity type
Corporation
Revenue range
Decline to Disclose
Industry filed under
Biotechnology

Executives, directors and promoters

As listed on the latest Form D.

    13 more people on the filing with a free account

    Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.

    Investors

    5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.

    The investor database is part of the paid tier

    For Caredx we have 2 shareholders with 5% or more.

    It is included for signed-in readers who have credit, along with the daily news digest. Credit is also what pays for AI device summaries.

    Latest FDA decisions

    Search the Clearance Tracker

    Device trials

    Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.

    Open in the Trial Radar

    Reports received

    0

    Received Nov 1, 2025 to Nov 19, 2026

    Malfunction reports

    0

    Injury reports

    0

    Death reports

    0

    Adverse event reports received per month

    Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.

    Search the MAUDE Monitor

    No reports to chart for this view.

    Device types named most often

    Last 12 months, by FDA product code. A company that sells more gets more reports.

    No device types to rank.

    Brand names named most often

    Last 12 months, as written on the reports. One product can appear under several spellings.

    No brand names to rank.

    Recent recalls

    From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.

    No recalls under this name in FDA's data.

    Back to all tools

    For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.